Echelon Biosciences Inc.

Lipid (phosphoinositide (PI) and isoprenoid) cell signalling research and product development

Echelon Bisciences was founded in 1997 by University of Utah scientists.
It was incorporated as Echelon Research Laboratories, Inc. on 3 October 1997.
The company has now changed its name to Echelon Biosciences Incorporated.
In 2005 Echelon was taken over by Aeterna Zentaris (NAS: AEZS).

W. Tim Miller (President)
John B. Wirthlin (Director of Marketing and Business Development)

675 Arapeen Drive, Suite 302
Salt Lake City, UT 84108
USA
Phone: +1-801-588-0455
Fax: +1-801-588-0497

The PIP Array™ features 4 cm by 4 cm nitrocellulose membranes. Each of the eight synthetic phosphatidylinositol phosphates (PtdIns) is spotted and dried onto these in seven different concentrations. The array can be applied to the determination of relative selectivity and sensitivity to phosphoinositides. This array was the first commercially available nonradioactive high-throughput screening platform that can test PI 3-kinase activity in a cell.